Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
Specific Diagnostics Announces that NIAID has Awarded the Company a Further $2.9 million for the Commercial Development of the Reveal Rapid Antibiotic Susceptibility Testing (AST) System
MOUNTAIN VIEW, California, June 2, 2020 – Specific Diagnostics today announces that the National Institute for Allergy and Infectious Disease (NIAID) has awarded a second major grant to drive the commercial introduction of Specific’s Reveal system, which provides quantitative determination of antib [...]
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
- CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology - Precision NanoSystems will lead RNA vaccine formulation development - CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials Tianjin, China and Vancouver, Canada – CanSin [...]
Nivagen Pharmaceuticals Closes $16 Million Growth Equity Financing from Telegraph Hill Partners
Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities Sacramento, Calif.—(May 19, 2020)—Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals company, announced the closing of a $16 million equity financing round led by Telegraph Hill Pa [...]